What Late Stage Lung Cancer Patients Should Know About Immunotherapy During Coronavirus
SHARE

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated January 6th, 2023

What Late Stage Lung Cancer Patients Should Know About Immunotherapy During Coronavirus

Medical Source: Dr. Brendon Stiles
Montefiore and Albert Einstein College of Medicine
×

Immunotherapy Treatment Impacted By Covid-19

  • The data to develop guidance around treatment for cancer during Covid-19 is extremely early and uncertain
  • Physicians are not entirely sure how immunotherapy drugs will interact with Covid-19
  • You should consult your physician on whether to go ahead with treatment, and possibly get multiple opinions
If you’re a lung cancer patient on immunotherapy treatments, you are very likely wondering how your care will be effected by the COVID-19 pandemic. Of course, the possibility of getting coronavirus is a scary scenario for any cancer patient, but what’s more challenging is that there’s very little data to guide specific decisions for specific coronavirus treatment protocols.

“We really don’t know what the interaction of (immunotherapy) is going to be with the virus,” Dr. Brendon Stiles, a thoracic surgeon at Weill Cornell Medicine, tells SurvivorNet. “You could probably argue both ways that it may completely throw your immune system out of whack and predispose you to infection [or] maybe because you’re getting an immune stimulus, you might be able to fight off viruses better. We’re going to need a lot more data to understand that better.”

Read More
One of the main concerns facing physicians is potential side effects of any cancer treatment. “Where we could potentially run into trouble is that some of these (immunotherapy) drugs can cause pneumonitis, inflammation in the lungs. Chemotherapy can cause immunosuppression so that the combination of those may be tough for some patients to take,” says Dr. Stiles.

 

“It’s going to depend on situation,” Dr. Stiles says. “If a patient is at the start of their stage four course and treatment needs to get started, I personally would offer our standard treatment. If they’ve already had twelve months of immunotherapy and they’re doing well, and things are going okay, maybe it makes sense to skip the dose to keep them away from a medical establishment right now and keep them safe.”

Immunotherapy In Lung Cancer Treatment

Immunotherapy treatment marks a revolution in lung cancer care. The new class of immunotherapy drugs, also known as checkpoint inhibitors, have had encouraging survival rates when used by lung cancer patients.

In a separate interview with SurvivorNet, Dr. Stiles says that some late stage cancer patients have benefited from immunotherapy treatment without chemotherapy being involved.

"If you have high expression of a protein that we know is targeted by immunotherapy, you may just get immunotherapy alone,” Dr. Stiles tells SurvivorNet.

Immunotherapy uses the power of your own immune system to recognize cancer cells and kill them. It has been especially successful in late stage lung cancer, but Dr. Stiles says that clinical trials are developing so it can treat early-stage lung cancer as well.

Learn more about SurvivorNet's rigorous medical review process.

Dr. Brendon Stiles is a thoracic surgeon at Montefiore Health System. Read More

NOW
PLAYING
What Do People With Lung Cancer Need to Know About COVID-19?
NOW
PLAYING
Continue Cancer Screenings Through COVID-19
NOW
PLAYING
As Screenings Return, Those At Risk Should Request Priory Scheduling
NOW
PLAYING
How Can African-American Communities Trust Clinical Trials During Coronavirus? Trust Must Be Built Over Time, Says Expert
NOW
PLAYING
To Stop COVID-19 From Killing So Many African-Americans - Address Poverty, Smoking & Obesity, Leading Expert Says
NOW
PLAYING
4-Year-Old Matteo Has Brain Cancer Treatment Delayed-- He and His Mom Have Coronavirus-- I Want To Tell Him It's Ok Mommy's Here
Continue The Journey

Explore: Living With Cancer

Related Articles

New FDA Approvals & More Hope Coming Down the Line — SurvivorNet Highlights the Biggest Moments in Cancer News This Year

‘Come On Down’ For Awesome News! Utah Woman Goes on The ‘Price is Right’ To Announce She is Cancer Free

Overview

New CML Approval: Leading Leukemia Expert on the ‘Significant Improvement’ Asciminib (Scemblix) Offers Patients as a First-Line Treatment Option

‘Antiques Road Show’ Star, 38, Battling Brain Cancer Says She Faces More Treatment After Scans Revealed Her Brain Tumor Is ‘Regrowing’

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider